Lauren Buchanan, MA, Managing Editor

Founder Matthew Brunner MHS, PA-C, and Elevate Derm's leadership team explain why the meeting was founded in 2020 and its growth to fit today's treatment landscape.

One of the many minds behind innovative Fall Clinical Dermatology sessions gives a sneak peek of the top 5 things to look forward to during this year's meeting.

Caregivers of children with AD also experience increased levels of stress, anxiety, depression, and suicidal ideation, extending the impact beyond the affected individual to their families.

Sometimes patients are unsure of what they can request from an employer for their skin conditions, and advice from a trusted clinician about reasonable accommodations can serve as an extra step to build their confidence to continue their career.

Skin conditions can be associated with the presentation, progression, and treatment of breast cancer.

The data presents compelling evidence for the sustained efficacy and safety of the oral JAK1 inhibitor in the treatment of moderate to severe atopic dermatitis over an extended 140-week period.

Kristina Collins, MD, delves into the importance of being present in the moments you have control over and making self-care a priority on the road.

AD in the elderly demands specialized attention, considering the unique challenges presented by concurrent skin conditions and underlying systemic diseases.

Discover the top pearls and takeaways from sessions at Maui Derm NP+PA Fall 2023 in Asheville, North Carolina.

Non-physician posts accumulated more than 3 times the number of views compared to those created by physicians. Among physicians, dermatologists demonstrated higher average view counts compared to non-dermatologists.

These insights highlight the crucial role of systemic therapies in the comprehensive management of moderate to severe atopic dermatitis.

New and emerging therapies to treat a variety of skin conditions were presented by George Martin, MD, and Ted Rosen, MD.

October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.

The hair guru explains how he opened up the first dermatology practice dedicated to hair, pearls from his session, innovative therapies, and research he has recently submitted.

Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.

Trifarotene emerges as an effective and well-tolerated solution for acne across diverse populations.

The distribution of eyebrow and eyelash hair loss in relation to the severity of scalp hair loss remains underexplored, and this study established baseline characteristics.

Matthew Zirwas, MD, addressed solutions to the toll consistent handwashing, sanitizing, and wearing gloves can take on hands.

Researchers found that continued use of once-daily subantibiotic dose oral doxycycline 40 mg modified-release capsules significantly reduced the relapse rate and inflammatory lesion counts in patients with moderate-to-severe rosacea.

We had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.

In a Q&A, she shares pearls from her personal experiences treating pediatric acne and other underlying conditions that may require a multidisciplinary plan.

The intense itching associated with prurigo nodularis significantly affects patients’ quality of life, leading to higher rates of anxiety, depression, and sleep disturbances.

Leaders in dermatology shared a review of thought-provoking literature published this year to consider in practice, diagnostic solutions, and treatment strategies.

The phase 3 trial of once-daily roflumilast foam has shown promising results in the treatment of seborrheic dermatitis.

A poster session at Maui Derm NP+PA Fall delves into data surrounding the use of olive oil in therapeutic applications.

He delves into one of his most challenging recent cases, the evolution of treatment options, and strategies to think outside of the box in diagnostic and therapeutic approaches.

She shares her top 5 considerations for all dermatology drug prescribers.

Discover the data-driven pearls that will be presented in the main program at Maui Derm NP+PA Fall 2023.

Connect with us in-person and discover innovative practice pearls throughout the weekend.

Ruth Ann Vleugels, MD, and Christopher Bunick, MD, agreed that the long-term safety data for JAK inhibitors makes them preferable to systemic steroids.